The publication of positive trial results typically leads to increased investor confidence, potentially boosting stock prices. The successful trial outcomes and plans for international expansion indicate a positive growth trajectory for Altamira Therapeutics, which could lead to increased revenues and market share. This news is directly related to CYTO and is critical for investors, as it signals potential future success and expansion.